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S T R U C T U R A L  B I O L O G Y
2.7 Å cryo-EM structure of rotavirus core protein VP3, 
a unique capping machine with a helicase activity
Dilip Kumar1*, Xinzhe Yu1*, Sue E. Crawford2, Rodolfo Moreno1, Joanita Jakana1,3, 
Banumathi Sankaran4, Ramakrishnan Anish1, Soni Kaundal1, Liya Hu1, Mary K Estes2,5, 
Zhao Wang1,3,6†, B. V. Venkataram Prasad1,2†
In many viruses, including rotavirus (RV), the major pathogen of infantile gastroenteritis, capping of viral messenger 
RNAs is a pivotal step for efficient translation of the viral genome. In RV, VP3 caps the nascent transcripts synthesized 
from the genomic dsRNA segments by the RV polymerase VP1 within the particle core. Here, from cryo–electron 
microscopy, x-ray crystallography, and biochemical analyses, we show that VP3 forms a stable tetrameric assembly 
with each subunit having a modular domain organization, which uniquely integrates five distinct enzymatic steps 
required for capping the transcripts. In addition to the previously known guanylyl- and methyltransferase activities, 
we show that VP3 exhibits hitherto unsuspected RNA triphosphatase activity necessary for initiating transcript 
capping and RNA helicase activity likely required for separating the RNA duplex formed transiently during endogenous 
transcription. From our studies, we propose a new mechanism for how VP3 inside the virion core caps the nascent 
transcripts exiting from the polymerase.
INTRODUCTION
The 5′-end capping of nascent pre-mRNA is an evolutionarily con-
served process in eukaryotes and viruses. The capping of the pre- 
mRNA involves three sequential enzymatic steps. First, the removal 
of terminal phosphate from 5′-pppNpRNA through RNA triphos-
phatase (RTPase) activity; second, covalent addition of guanosine 
monophosphate (GMP) to the RNA to form GpppNpRNA involving 
guanylyltransferase (GTase) activity; and last, a two-step methyl-
transferase (MTase) activity, using S-adenosyl-l-methionine (SAM) as 
the methyl donor, leading to the formation of cap-0 (m7GpppRNA) 
and cap-1 (m7GpppNm2pRNA). Viruses implement various strategies 
to perform capping of nascent viral transcripts to mimic host mRNA 
capping, which allows utilization of the host machinery for efficient 
translation of viral mRNA as well as evasion of the host antiviral 
innate immune response (1, 2). In viruses from the Reoviridae family 
such as rotavirus (RV), reovirus, and bluetongue virus (BTV), which 
have multiple genomic double-stranded RNA (dsRNA) segments, 
the 5′-end cap on the positive-sense RNA strand is essential not only 
for efficient translation in host cells but also to initiate endogenous 
transcription from the genomic dsRNA by the viral RNA-dependent 
RNA polymerase (RdRp), a process that occurs within the constrained 
environment of the capsid interior (3–5).
In RV, which is the major causative agent of life-threatening 
diarrhea among children (6), VP3 mediates capping of the nascent 
transcripts synthesized by the viral RdRp, VP1, during endogenous 
transcription. Both VP3 and VP1 together with the 11 dsRNA 
segments are encapsidated in the core of the RV particle that is sur-
rounded by three concentric icosahedral capsid layers formed by 
four structural proteins (VP2, VP6, VP7, and VP4) (7). Although 
the structures of the RV proteins that constitute the multilayer capsid 
and that of VP1 are well defined, the structure of VP3 has remained 
elusive. In addition, how it caps the nascent transcripts synthesized 
by VP1, within the capsid interior, has been a mystery. Previous 
biochemical studies showed that VP3 exhibits RNA binding, GTase 
and MTase activities required for capping (8–10), but it has been 
unclear whether VP3 exhibits RTPase activity, the first step in mRNA 
capping, or whether it is assisted by another viral protein. If VP3 has 
RTPase activity, then a relevant question is how does it bind to 
nascent transcripts and which domain is involved in this process. 
During endogenous transcription, as suggested by Jenni et al. (4), 
the nascent transcripts synthesized by VP1 transiently form a duplex 
with the negative-strand template of the dsRNA, which needs to 
be separated before the capping of the transcripts. As VP1 is not 
known to exhibit helicase activity, it remains unknown how strand 
separation occurs before capping and whether VP3 is involved in 
this process. In addition to its function as a capping enzyme, VP3 
also plays an important role during RV replication as an antagonist of 
the antiviral 2′-5′-oligoadenylate synthetase/ribonuclease L (RNase L) 
pathway with its phosphodiesterase (PDE) activity accomplished 
through its C-terminal PDE domain (11, 12). To gain mechanistic 
insights into the multiple functions of this enigmatic protein, we 
have determined its full-length structure and analyzed its bio-
chemical activities.
RESULTS
Recombinant VP3 exhibits GTase and MTase activities
Following successful expression of the full-length RV VP3 (amino 
acid residues 1 to 835; ~98 kDa) using the baculovirus expression 
system, the purified recombinant VP3 was used to determine the 
cryo–electron microscopy (cryo-EM) structure to a resolution of 
~2.7 Å (Fig. 1, A to C) and further functional characterization. 
Before structural analysis, we confirmed that the recombinant VP3 
exhibits the previously characterized GTase and MTase activities 
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required for mRNA capping (9, 10). In addition to autoguanylylation, 
as previously shown to infer GTase activity, we demonstrated a 
direct transfer of guanylyl group from guanosine triphosphate 
(GTP) and similarly of methyl group from SAM onto the rotaviral 
transcript (segment 10) (fig. S1, A to D). An unexpected finding from 
this experiment is that the GMP transfer is more efficient in the presence 
of SAM, suggesting the N7-methylation of the GMP takes place 
before GMP transfer onto the 5′-end of the transcript (fig. S1B). The 
sequential steps of RNA capping in RV appear to follow a similar 
pattern as in alphaviruses, wherein GMP is methylated before the 
transfer of the guanylyl group onto the mRNA (13). This finding 
also strengthens previous reports that show that the addition of 
SAM is critical for in vitro endogenous transcription of full-length 
transcripts by double-layered particles (DLPs) (14).
VP3 forms a stable tetramer
Our biochemical analysis of recombinant VP3 using size-exclusion 
chromatography and analytical ultracentrifugation (AUC) analysis 
showed that VP3 formed a tetramer (fig. S1, E and F). The VP3 
tetramer remained stable in a wide range of salt concentrations 
(50 mM to 1 M NaCl) and pH (5.5 to 9.0), further indicating that 
VP3 intrinsically favors this oligomeric state (fig. S1G). The cryo-EM 
structure of VP3 was determined from the images of a frozen- 
hydrated sample using a well-established single-particle reconstruc-
tion workflow (fig. S2, A to E). The cryo-EM reconstruction showed 
a tetrameric assembly, as expected from the biochemical analysis, with 
a D2 symmetry formed by two antiparallel dimers (Fig. 1, A and B, 
and movie S1). The cryo-EM map was of sufficient quality, with the 
majority of the side-chain densities and the loop regions well defined, 
for ab initio model building (Fig. 1E, fig. S3A, and movie S2). The 
previously determined crystal structure of the C-terminal VP3-PDE 
domain (residues 694 to 835) was unambiguously identified in the 
model (12). Other domains were identified on the basis of similarities 
with the domains in the structure of BTV VP4 (15), the closest 
structural homolog of VP3 (16), and other structural homologs as 
revealed by the Dali search (17). In addition, the cryo-EM model of 
the monomer allowed phasing of the ~3.5 Å x-ray diffraction data 
of the native VP3 crystal, which otherwise could not be phased. The 
x-ray structure of VP3 showed a similar tetrameric association of 
VP3 monomeric subunits, as observed by cryo-EM (fig. S3, B and 
C), and allowed recognition of other subtle features as noted below. 
The subunits in the tetramer interact extensively with a total calculated 
buried surface area of ~17,080 Å2, further strengthening the notion 
that the tetrameric assembly is the most favored state for VP3.
VP3 exhibits a modular domain organization for  
enzymatic activities
The VP3 monomer exhibits a modular organization with five distinct 
domains: N-terminal kinase-like (KL) domain (residues 1 to 181), 
guanine-N7 MTase (N7-MTase) domain (residues 182 to 255 and 
441 to 560) interspersed around the ribose 2′-O-MTase domain 
(residues 256 to 440), and GTase domain (residues 561 to 688) con-
nected to the C-terminal PDE domain (residues 694 to 835) through 
a short linker (Fig. 1, B to D, and movie S3). Although the overall 
Fig. 1. Cryo-EM single-particle reconstruction and atomic model of VP3. (A) The cryo-EM structure of the VP3 tetramer [Electron Microscopy Data Bank (EMDB) 
ID: EMD-0632) is shown along the twofold axes of the D2 symmetry. Individual subunits chain A (aqua blue) and chain B (lemon) and their twofold related symmetry pairs 
chain A′ (sky blue) and chain B′ (honey dew) are shown in shades of blue and yellow. The top panel shows a dimeric subunit with one twofold axis, and the bottom panel 
shows second twofold axis. (B) Ribbon representation of the atomic model of VP3 tetramer relative to the orientation in the top panel of (A). Each individual dimer is 
formed by two antiparallel monomers. Individual domains are shown in separate colors: kinase-like (KL) domain (red), guanine-N7 MTase (N7-MTase) domain (green), 
2′-O-MTase domain (orange), GTase domain (cyan), and PDE domain (magenta). The same coloring scheme is used in other figures. (C) Domain demarcation along the 
VP3 peptide chain sequence based on the structural annotation. (D) Modular domain organization of VP3 monomer structure. (E) A representative sample of the 2.7 Å 
cryo-EM map showing side-chain densities (from the 2′-O-MTase domain) along with the modeled structure. See movies S1 to S3.
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domain organization in the VP3 monomer is similar to BTV VP4, 
with the catalytic residues in the GTase and MTase domains loca-
tionally conserved, there are notable differences in the relative 
orientations of the domains resulting in an overall root mean square 
deviation of 5.4 Å for the matching C atoms when the two structures 
were superimposed (fig. S4A). A distinctive difference between the 
RV VP3 and the BTV VP4 is the absence of the PDE domain in 
the latter and comparatively longer N-terminal KL domain (fig. S4, 
A and B).
The GTase domain in VP3 shows the expected features consistent 
with its enzymatic activity of adding a GMP to the nascent RNA 
(Fig. 2A). In both the cryo-EM and x-ray maps of VP3, an additional 
density is located at the GTase catalytic center that was modeled 
as GMP (Fig. 2B and fig. S5A). This modeling was confirmed by 
simulated annealing difference maps using x-ray diffraction data. 
The GMP is coordinated with the conserved residues Ser570, His574, 
Arg577, Tyr588, Arg591, His612, His650, and Glu654 (Fig. 2B and figs. S5A 
and S7). As the GMP was not added during either the purification 
or the crystallization procedures, it is likely that it copurified with 
VP3. The location of the GMP and the interacting residues are consist-
ent with previous mutational studies, which indicated that mutating 
Arg591, His612, or His650 abrogates autoguanylylation activity (16). 
The x-ray map also showed a bound sulfate interacting with Arg571, 
a conserved residue in group A RVs (figs. S5B and S7). A similarly 
bound sulfate is also observed in the structure of the human GTase 
domain (18) and is suggested to be analogous to the phosphate 
released from the GTP during the GTase reaction. The GTase domain 
also participates in the VP3 dimer formation through interactions 
Fig. 2. VP3 domain organization and structural comparisons. (A) Structural comparison of the GTase domains in RV VP3 (cyan) and BTV VP4 (light gray) showing 
similar structural folds. GTase domain of VP3 additionally participates in the interaction with the KL domain (helices 165 to 178, shown in red) from the neighboring sub-
unit at the dimeric interface (circled). (B) Electron density for the GMP observed at the catalytic center of GTase domain in the x-ray structure. Conserved catalytic residues 
interacting with the GMP are denoted. (C) Structural comparison of the guanine N7-MTase (green) and (D) 2′-O-MTase (orange) domains in RV VP3 with those in BTV VP4 
(light gray). Note that the substrate binding region shows ~50% conservation in amino acid sequences. The 2′-O-MTase domain also contains the well-characterized 
catalytic KDKE tetrad motif (in asterisks), which is a conserved feature of MTase domains of other capping enzymes. N- and C-terminal residues of the MTase domains in 
RV VP3 (L181 to L560 for N7-MTase and I256 to D440 for 2′-O-MTase) and BTV VP4 (R109 to D509 for N7-MTase and T175 to D377 for 2′-O-MTase) are indicated (domain 
colors as in previous figures).
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with the N-terminal KL domain of the neighboring monomer 
subunit (Fig. 2A).
The sequential addition of cap-0 and cap-1 to the 5′-end of the 
nascent RNA is performed by the N7-MTase and 2′-O-MTase 
domains, respectively. Despite low sequence similarity, the MTase 
domains in RV VP3 are structurally similar to the MTase domains 
in BTV VP4. Both 2′-O-MTase and N7-MTase domains contain the 
expected class I SAM-dependent MTase fold with six β-strands 
surrounded by three helices. While the 2′-O-MTase domain has the 
characteristic Lys260-Asp340-Lys383-Glu408 (KDKE) catalytic tetrad, 
this motif is not present in the N7-MTase domain (Fig. 2, C and D). 
Both of the MTase domains are extensively involved in interactions 
with the PDE and GTase domains at the dimer interface with two-
fold related subunits (fig. S4, C and D). The N7-MTase domain 
contains a positively charged cavity beneath a loop region that is 
likely the site for nucleotide binding (fig. S5C). The corresponding 
cavity in the BTV VP4 N7-MTase domain structure contains a 
bound S-adenosyl-l-homocysteine (SAH) albeit it is negatively 
charged (fig. S5D). Although the MTase domains in VP3 exhibit 
overall structural similarities with the corresponding domains in 
BTV VP4, the residues implicated in SAM/SAH and RNA substrate 
binding in the BTV VP4 structure are not completely conserved in 
VP3, suggesting a slightly altered mechanism for substrate recognition 
and binding in RV VP3 (Fig. 2, C and D, and table S3).
The PDE domain of VP3 exhibits a novel RTPase activity
Before the GTase and MTase activities, an obligatory step in 5′-mRNA 
capping is the removal of the terminal -phosphate (RTPase activity) 
from the nascent transcript (1). Previous studies suggested that the 
GTase and MTase activities are associated with VP3 (9, 10), yet the 
RTPase activity was not demonstrated. Among the RV proteins, 
nonstructural protein NSP2 is the only protein known to exhibit 
RTPase/NTPase (nucleoside triphosphatase) activity (19). The 
lack of NSP2 inside the core particle raises the question of how 
mRNA capping takes place in RV during endogenous transcription. 
With this question in mind, we investigated whether purified VP3 
exhibits RTPase activity. Our in vitro assays clearly demonstrated 
that VP3 exhibits RTPase activity (Fig. 3A). We further investigated 
which region or domain of the VP3 could be responsible for the 
RTPase activity. We hypothesized that the distal and exposed 
PDE domain might be an appropriate candidate for the RTPase 
activity. Our in vitro biochemical assay confirmed that the PDE 
domain alone exhibits RTPase activity in a dose-dependent manner 
(Fig. 3A).
To perform RTPase activity, the PDE domain should first bind 
to the single-stranded RNA (ssRNA) substrate, and biolayer inter-
ferometry (BLI) experiments showed that both full-length VP3 and 
the PDE domain bind to 8-mer biotinylated ssRNA (Fig. 3, C and D) 
with nanomolar affinity. The best fit of the binding sensograms in 
each case was with 2 (RNA):1 (VP3 or PDE) (R2 ~ 0.99, 2 ~ 0), 
suggesting the possibility of two simultaneous RNA binding modes 
of similar affinity. The structure of the PDE domain clearly shows a 
surface-exposed cleft with an effective radius of 4.69 Å lined pre-
dominantly by positively charged residues (fig. S6, A to C), which is 
likely the site for ssRNA binding. RNA binding to the PDE domain 
of VP3 is further supported by our low-resolution (~12 Å) cryo-EM 
reconstruction map of VP3-ssRNA complex (unmodified 8-mer) in 
which we could unambiguously locate 8-mer ssRNA bound to the 
cleft in the PDE domain (Fig. 3B and fig. S8). The reconstruction 
shows that RNA binds to only one of the four PDE domains in the 
tetramer. In the cryo-EM images, we observed that several VP3 
tetramers are decorated with more than one RNA; however, the 
majority of the VP3 tetramers in these images show binding with 
only one RNA molecule, and these particles were the ones selected 
for reconstruction (fig. S8). There are several factors such as binding 
kinetics, incubation time, RNA concentration, and nature of RNA 
used in our experiments, which might have affected the simultaneous 
binding of RNA to all four PDE domains in the tetramer. Nonethe-
less, our results clearly demonstrate the ability of VP3 to bind RNA 
through its PDE domain.
Association of RTPase activity with the PDE domain is indeed 
unique. The fold of the PDE domain is highly conserved among the 
proteins that belong to the 2H PDE superfamily, which all share two 
similarly spaced H-X-T-X motifs (20). This family of proteins includes 
several cellular proteins involved in a variety of signaling processes 
(20). To our knowledge, RTPase activity has not been shown to be 
associated with any of these proteins. Whether VP3 is a singular 
example or whether other cellular proteins with this fold also exhibit 
RTPase activity remains an open question.
VP3 exhibits RNA helicase activity
A recent report by Jenni et al. (4) showed that the nascent transcript 
and the negative-strand template form a transient duplex inside the 
catalytic cavity of VP1 during endogenous transcription. Considering 
that there is no reported helicase activity for VP1 and that the RNA 
duplex has to be separated for the nascent transcript to interact 
with VP3 for capping, we investigated whether VP3 exhibits a 
helicase-like activity. Our fluorescence-based assay showed that 
VP3 indeed exhibits helicase activity and that this activity is modu-
lated by the addition of adenosine triphosphate (ATP) and MgCl2 
(Fig. 3, E and F, and fig. S6D). VP3 exhibits basal helicase activity 
even in the absence of ATP (Fig. 3F). However, depletion of MgCl2, 
with the addition of EDTA, abolishes helicase activity, suggesting 
that divalent metal ions are critical for VP3-associated helicase ac-
tivity (fig. S6D). We have also observed a decrease in the helicase 
activity at higher ATP (>4 mM) and MgCl2 (>3 mM) concentra-
tions, suggesting that free ATP and free MgCl2 hinders the helicase 
activity, similar to what was previously observed in the case of the 
NS3 helicase of hepatitis C virus (21). We further tested whether this 
activity is preferentially affected by a particular nucleoside triphos-
phate (NTP) and found that ATP and UTP (uridine triphosphate) 
are preferred over GTP and CTP (cytidine triphosphate) (fig. S6E).
On the basis of the structural features of VP3, it is unlike any 
known RNA helicase. It is unclear as to the precise mechanism by 
which VP3 unwinds the RNA duplex and which specific domain(s) 
in VP3 are involved in this process. It is likely that the PDE domain, 
because of its distal location and the associated RNA binding and 
RTPase activities, and the GTase domain, because of its inherent 
NTPase activity, act in a concerted manner to unwind the RNA 
duplex. Our conjecture is that while the PDE domain binds to one 
strand of the RNA duplex, an additional site is created as a result of 
possible conformational changes due to NTP hydrolysis, which also 
might fuel the unwinding process that will engage the other strand. 
Because of the inherent nature of VP3 to form a highly stable 
tetramer, it is also likely that such an oligomeric assembly is critical 
for this function. Our attempts to destabilize the tetramer into any 
smaller oligomeric states to examine whether the tetrameric assembly 
is crucial for the helicase activity were not successful.
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DISCUSSION
Here, by  using a combination of cryo-EM, x-ray crystallography, and 
biochemical assays, we have provided a detailed picture of the structure- 
activity relationship in the RV VP3. In addition to determining the 
atomic structure, we have discovered several previously uncharacterized 
features associated with this multifunctional protein. Our results show 
that recombinant VP3 not only exhibits GTase and MTase activities 
but also exhibits previously undiscovered RTPase and RNA binding 
activities, indicating that VP3 has all the necessary properties re-
quired for 5′-RNA capping. Another fascinating finding is that VP3 
exhibits a novel RNA helicase activity that can be modulated by ATP 
and the divalent metal ion MgCl2. Such a confluence of various 
enzymatic activities including helicase activity embedded in a tetrameric 
assembly is indeed unique and unprecedented. One of the unex-
pected results from our studies is that the recombinant VP3 forms a 
stable tetramer and that it maintains its tetrameric assembly under a 
variety of conditions. This raises several intriguing questions such 
as whether VP3 is incorporated into the particle as a tetramer and 
if so, how such an oligomeric state facilitates capping of nascent 
transcripts within the confines of the RV capsid interior.
Transcription of the dsRNA by VP1 followed by capping of the 
nascent transcript occurs within the intact DLP, which is formed by 
the removal of the outer capsid layer during the process of virus 
entry into host cells (7, 22). Cryo-EM reconstructions of actively 
transcribing DLPs have shown that the capped mRNA exits through 
the aqueous channels at the fivefold axes of the DLP (4). Previous 
in vitro biochemical studies on transcribing particles show that 
transcripts are capped by the time the sixth or seventh nucleotide is 
synthesized by VP1, suggesting that VP3 is in close proximity to 
VP1 during endogenous transcription (14). Although asymmetric 
reconstructions of the DLPs have unequivocally demonstrated that 
VP1 is attached to the innermost layer of the core formed by VP2 at 
Fig. 3. VP3 exhibits RTPase and RNA helicase activity. (A) An autoradiograph showing a VP3 or PDE domain concentration-dependent decrease in the 5′-end [-32P] 
GTP-labeled RNA band intensity confirms that VP3 exhibits RTPase activity and that this activity is associated with the PDE domain. RV NSP2, which was previously shown 
to have RTPase activity, is used as a positive control. The RTPase activity of VP3 is inhibited in the presence of EDTA indicating that the RTPase activity of VP3 is metal 
dependent. (B) Low-resolution cryo-EM single-particle reconstruction of VP3 in complex with 8-mer single-stranded RNA (ssRNA), suggests that the RNA binds near a cleft 
in the PDE domain (black arrow). The difference map was obtained using low-resolution cryo-EM map from apo-VP3 and cryo-EM map from VP3-ssRNA complex in 
Chimera. (C and D) Biolayer interferometry (BLI) analysis of RV VP3 and PDE domain binding with ssRNA (8-mer) shows that both full-length VP3 and PDE domain bind 
with ssRNA with similar nanomolar affinity. The two–binding site model fits the data with excellent R2 (~0.99) and 2 (~0) values. (E and F) Fluorescence-based helicase 
assay. The 6-fluorescin amidite (6-FAM)–labeled RNA strand is quenched by a complementary quencher [Black Hole Quencher (BHQ)–labeled] strand in dsRNA. Increased 
fluorescence intensity with increasing concentrations of VP3 indicates the strand separation confirming the dsRNA helicase activity of VP3. Helicase activity requires the 
full-length VP3; the PDE domain alone does not show any significant increase in fluorescence intensity. (F) The fluorescence intensity is also modulated by adenosine 
triphosphate (ATP) concentrations.
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the fivefold axes (4, 23), VP3 was not visualized in these reconstruc-
tions, and thus, how VP3 coordinates capping of the nascent mRNA 
exiting from VP1 is unclear. The absence of VP3 in the asymmetric 
reconstructions perhaps suggests that VP3 is not firmly anchored to 
VP1 (or VP2) and that its spatial arrangement inside the particle 
interior is dynamic.
On the basis of our studies, we envision a plausible functional 
model for endogenous transcription that incorporates the various 
novel observations that we have made for VP3. Although the oligo-
meric state of VP3 inside the RV particle is yet unknown, on the 
basis of our observations that VP3 forms highly stable tetramers, we 
hypothesize that VP3 is incorporated into the particles as tetramers. 
In our model, a VP3 tetramer is associated with each of the non-
redundant pairs of neighboring VP1 molecules inside the core, noting 
that the distance between the RNA exit channels of the neighboring 
VP1 (~130 Å) matches well with the length of the VP3 tetramer 
(~126 Å) (Fig. 4A). The distance between the exit channel in the 
VP1 and the nearest PDE domain in VP3 would approximate to a 
distance that is spanned by ~5 nucleotides, which is consistent with 
the biochemical studies that suggest that transcripts are capped by 
the time the sixth or seventh nucleotide is synthesized by VP1 (14). 
During endogenous transcription, the duplex formed by the template 
strand and the nascent transcript that exits from VP1 is separated 
by the RNA helicase activity associated with VP3. While the transcript 
continues through the process of capping, the template is returned 
to form a duplex with the partner positive strand to go through the 
iterative process of transcription. In this model, following the removal 
of the -phosphate by the PDE domain, the emerging transcript 
transits through the GTase domain and then through the MTase 
domains of the twofold related subunit for subsequent steps of capping. 
The capped transcript then exits via the closest channel at the fivefold 
axis in the VP2 layer (Fig. 4B). A similar path for a second transcript 
is envisioned for the other end of the VP3 tetramer that is closest to the 
neighboring VP1. Similar association of VP3 tetramers with other 
nonredundant VP1 pairs will ensure independent and simultaneous 
production of capped transcripts during endogenous transcription. 
Fig. 4. Proposed model for mRNA capping during endogenous transcription. (A) The VP3 tetramer is positioned inside the core particle between two VP1 molecules 
such that the PDE domains on either side of the VP3 tetramer face the transcript exit channels in the two neighboring VP1 molecules at each fivefold axis. Note that the 
length of the VP3 tetramer (~126 Å) matches the distance between the two VP1 exit channels (~130 Å). Similar placement of VP3 tetramers between the other five nonredundant 
VP1 pairs inside the core particle is envisioned. The VP6 and VP2 layers of the DLP are shown in blue and green shades, respectively, along with VP1 molecules (in gray) 
attached to VP2 at the fivefold axes. In this arrangement of VP3, two simultaneous capping activities can take place using the VP3 oligomeric assembly. The blue arrows 
indicate the possible path for the nascent transcript during the capping process. (B) Cartoon representation of a possible path for the nascent transcript emerging from 
VP1 through the PDE and GTase domains of one VP3 subunit and the MTase domains in the twofold related VP3 subunit, followed by its exit through the closest exit 
channel at the fivefold axes (denoted by a pentagon) of the DLP. Before capping, the RNA duplex formed by the nascent transcript and the template strand needs to be 
separated. The dsRNA helicase activity exhibited by VP3 suggests such a role for VP3 in RNA duplex separation with subsequent 5′-end capping.
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The proposed transcript path and the location of the VP3 parallel to 
the inner surface of VP2 layer are consistent with a previous pro-
posal by Estrozi et al. (24). Note that this model also works with an 
antiparallel dimer with the PDE domain of each subunit facing the 
adjacent VP1. However, the redundancy of the VP3 tetrameric 
assembly in the dynamic environment of the DLP during endogenous 
transcription may be advantageous to allow efficient capture the 
nascent transcripts exiting from the VP1.
Considering that the entire process of simultaneous transcription 
of the genomic dsRNA segments within the capsid interior resulting 
in the extrusion of the individual capped transcripts is necessarily a 
highly dynamic process, significant conformational rearrangements 
in VP3 have to be anticipated. Previous studies have indeed shown 
that VP1 undergo noticeable conformational changes during endog-
enous transcription (4, 23). Although the precise mechanism of 
RNA unwinding by the VP3 tetramer is yet to be determined, it is 
likely that the process of capping, which involves the passage of the 
nascent transcripts through the various catalytic domains, leads to 
significant conformational rearrangements within each VP3 subunit 
and also between the subunits in the tetramer to facilitate strand 
separation. Elucidation of the precise details of such a fascinating 
mechanism of how VP3 assists in strand separation and subsequent 
capping inside the constrained particle interior requires further 
structural and biochemical studies.
In conclusion, with the elucidation of the VP3 structure, we now 
have atomic structures of all six structural proteins that define the 
RV capsid. Our studies have revealed a number of hitherto un-
suspected novel aspects of VP3 and provided mechanistic insight 
into how this protein with its modular domain organization carries 
out multiple enzymatic activities essential for RV replication. Given 
its critical role during RV replication, VP3 is a potential target for 
designing antivirals to counter RV infection that is responsible for 
the deaths of ~200,000 children annually worldwide, and for such 
an endeavor, the VP3 structure provides a rational platform.
MATERIALS AND METHODS
Full-length VP3 and PDE cloning, expression, 
and purification
RV A VP3 sequence (accession number: ABC66299) was codon- 
optimized for the baculovirus expression system and cloned by Epoch 
Life Science into the pVL1392 vector using restriction sites (Not I/
Eco RI) with a C-terminal 6xHis tag. Recombinant baculoviruses 
were generated by the Protein and Monoclonal Antibody Production 
Core at Baylor College of Medicine. Viral plaques were screened for 
expression and an optimally expressing clone was scaled up for 
expression in Sf9 cells at a multiplicity of infection of 3 for 96 hours 
in the presence of protease inhibitor cocktail tablets (Thermo Fisher 
Scientific) at 24, 48, and 72 hours. Cells were washed with phosphate- 
buffered saline and pelleted down at 5000 rpm for 10 min at 4°C. Sf9 
cells were suspended in lysis buffer A [50 mM tris-HCl (pH 8.0), 
500 mM NaCl, 2 mM [Tris(2-carboxyethyl)phosphine hydrochloride 
(TCEP)], 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, 0.1% 
Triton X-100, 1× EDTA-free protease inhibitor cocktail, and 500 U of 
benzonase] and lysed using a homogenizer (KIMBLE Dounce tissue 
grinder set 15 ml, Millipore Sigma). The cell lysate was cleared by 
centrifugation at 27,216g (rotor: Beckman Coulter JA-25.50 fixed-angle 
aluminum rotor) for 60 min at 4°C, and the cleared supernatant 
was incubated with Ni-NTA (nitrilotriacetic acid) agarose resin 
(QIAGEN) preequilibrated with lysis buffer. Ni-NTA resin was 
washed with 15 to 20 column volumes of wash buffer B [50 mM tris-HCl 
(pH 8.0), 500 mM NaCl, 30 mM imidazole, and 5% glycerol], fol-
lowed by elution with elution buffer C [50 mM tris-HCl (pH 8.0), 
500 mM NaCl, 5 mM TCEP, 10% glycerol, and 300 mM imidazole]. 
Eluted protein was further purified on a gel filtration column 
(Superdex 200 Increase 10/300 GL, GE Healthcare) preequilibrated with 
gel filtration buffer D [50 mM tris-HCl (pH 8.0), 200 mM NaCl, 5 mM 
dithiothreitol (DTT), 10% glycerol, and 2 mM MgCl2]. Purified protein 
was concentrated using Amicon Ultra-15 Centrifugal Filter Units 
(Millipore Sigma) to ~7 mg/ml and used for further studies. The VP3-
PDE domain was purified using a previously established protocol (12).
Cryo-EM sample preparation, data collection, and  
single-particle reconstruction
For cryo-EM sample preparation, VP3 was diluted to ~0.5 mg/ml in 
a nonglycerol buffer [50 mM tris-HCl (pH 8.0), 200 mM NaCl, 5 mM 
DTT, and 2 mM MgCl2]. The sample was kept on ice before vitrifica-
tion (25) on the grid. A 3.0-l aliquot of VP3 was applied onto a 
200-mesh R1.2/1.3 Quantifoil holey carbon grid covered with a 
graphene oxide support film. After applying the sample, the grid 
was blotted and rapidly frozen in liquid ethane using a Vitrobot IV 
(FEI), with constant temperature and humidity during the process 
of blotting. The grid was stored in liquid nitrogen before imaging. 
Movie stacks (1690) were collected at 300 kV on a JEM-3200FSC 
electron microscope (JEOL) with an in-column energy filter (30-eV 
width) equipped with a direct electron detector K2 Summit camera 
(Gatan). Images were collected semiautomatically by SerialEM (26) 
in dose fractionation super-resolution counting mode at 40,000× 
magnification, corresponding to a calibrated physical pixel size of 
0.837 Å. The images were collected with a defocus range from −1.2 to 
−2.4 m. The total exposure time for the dataset was 10 s, leading to 
a total accumulated dose of 53 electrons Å−2 on the specimen. Each 
image stack was fractionated into 50 subframes, each with an accumula-
tion time of 0.2 s per frame. The final frame average was computed 
from averages of every three consecutive frames to correct beam- 
induced motion during exposure by MotionCor2 (27). The image 
in each frame was weighted according to radiation damage (28). CTF 
(Contrast Transfer Function) parameters of the particles in each frame 
average were determined by program e2ctf.py in EMAN2.2 (29) and 
Gctf 0.50 (30). In total, 133,712 particle images were automatically 
boxed out by e2boxer.py in EMAN 2.2 (31) with a box size of 
300 × 300 pixels using the averaged sum of 50 raw frames per specimen 
area. Two-dimensional (2D) reference-free class averages were com-
puted using RELION 2.1 (32). Initial models for every reconstruction 
were generated from scratch by e2initialmodel.py program (29) using 
selected good quality 2D averages with D2 symmetry based on the 
2D averages results. This initial model was low-pass–filtered to 60 Å, 
and further refinements were carried out using RELION 2.1 (32), with 
a search angle of 7.5° for 11 iterations and subsequently with an angular 
sampling of 0.9375° for 14 iterations. Particle images (70,892) were 
applied for a final reconstruction yielding a resolution of 3.4 Å at 
0.143 of the Fourier shell correlation and 2.7 Å after applying 
postprocessing. For cryo-EM data collection of the VP3-RNA 
complex, 8-mer ssRNA (5′-rG.rG.rC.rU.rU.rU.rU.rA-3′; Dharmacon 
Inc.) at a stoichiometric ratio of 1:1000 was incubated with VP3 for 
30 min at room temperature and purified by gel filtration (Superdex 
200 Increase 10/300 GL, GE Healthcare) column preequilibrated 
with nonglycerol buffer [50 mM tris-HCl (pH 8.0), 200 mM NaCl, 
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5 mM DTT, and 2 mM MgCl2]. We followed a similar protocol for 
VP3-RNA complex cryo-EM single-particle reconstruction. In 
total, 210,818 particles are boxed out, and 40,694 particles are used 
for final reconstruction of VP3-RNA density map at 11.8 Å resolu-
tion. The cryo-EM data acquisition, image processing, model build-
ing, and refinement statistics for both datasets are given in table S1.
Cryo-EM model building and refinement
The full-length VP3 model was built from a postprocessed density 
map at 2.7 Å resolution. We started de novo model building for full-
length VP3 by docking the C-terminal PDE domain [Protein Data 
Bank (PDB) ID: 4RPT] (12) and segmenting monomer map (segment 
map feature in Chimera) (33) from the tetramer cryo-EM map. The 
monomer model was constructed manually in Coot (34) using the 
C-terminal PDE domain as a starting point toward the N-terminal 
domain using secondary structure prediction to trace the chain 
direction. The monomer model was docked into the cryo-EM map 
in Chimera (35) to generate a tetramer model and refined using 
Rosetta density refinement (36) and phenix.real_space_refine (37) 
with secondary structure restraints. The model quality was validated 
using MolProbity (38) online server and EMRinger tool from the 
Phenix suite (39). Local resolution was estimated using ResMap 
(40). Detailed statistics for model building and refinements are given 
in table S1. The final maps and models were submitted to the Electron 
Microscopy Data Bank (EMDB) [ID: EMD-0632 (native VP3) and 
EMD-20159 (VP3-RNA)] and PDB (ID: 6O6B).
Full-length VP3 crystallization, data collection, data 
processing, and structure determination
Crystallization of full-length VP3 (concentration, ~7 mg/ml) was 
set up using the hanging drop vapor diffusion method at 20°C. The 
native crystals were obtained in a crystallization condition contain-
ing 15% ethanol, 0.1 M sodium citrate (pH 5.5), and 0.2 M Li2SO4. 
Selenomethionine-derived crystals were also obtained for use in 
SAD (single-wavelength anomalous diffraction) phasing. However, 
selenomethionine-derived crystals diffracted to very low resolution 
and could not be used for phasing and structure determination. The 
native VP3 crystals were harvested with 20% ethylene glycol as a 
cryoprotectant and flash-frozen in liquid nitrogen. The diffraction data 
were collected at Advanced Light Source, Lawrence Berkeley National 
Laboratory beamline 5.0.2 at a temperature of 100 K. The native 
crystal diffracted at 3.5 Å resolution and was further processed and 
scaled by HKL2000 (41). Because of the lack of a good structural 
model, including the BTV VP4 structure, phasing by molecular 
replacement (MR) was not successful. Subsequently, once the cryo-
EM model of VP3 was available, MR using the monomer subunit in the 
phaser module of Phenix suite (42) provided a unique MR solution. 
The model was further refined using Phenix Refine (43) and vali-
dated using MolProbity server (PDB accession code: 6O3V) (38). 
The ligand density was confirmed with the polder map module in 
Phenix suite (44). The data processing and model statistics are shown 
in table S2. The buried surface area was analyzed using PISA server 
(45). The electrostatic surface potential was rendered in PyMOL using 
APBS plugin (46, 47). The figures were prepared in Chimera (35), 
ChimeraX (48), and PyMOL (46). The PDE domain cavity radius was 
determined by 3V server (49). Multiple sequence alignment was 
performed by T-Coffee multiple sequence alignment online server 
(50), and structure-based sequence alignment was performed by 
ESPript 3.0 server (51).
Enzymatic characterization
VP3 autoguanylylation activity was performed with purified VP3 
by incubating increasing concentrations of VP3 with 1 l of [-32P] 
GTP in GTase buffer [20 mM tris-HCl (pH 7.4), 200 mM NaCl, 
5 mM DTT, 2 mM MgCl2, and 5% glycerol] in a 20-l reaction 
mixture at room temperature for 1 hour as previously described (9). 
The reaction mixture was resolved by SDS–polyacrylamide gel electro-
phoresis, followed by transfer onto a polyvinylidene difluoride 
(PVDF) membrane. The autoguanylylation was observed by auto-
radiography of the PVDF membrane. RV NSP2 was used as a nega-
tive control, and the vaccinia virus capping system (New England 
Biolabs Inc.) was used as a positive control. For showing direct 
transfer of GMP on transcript (GTase assay), we followed a previously 
established protocol with slight modification (52). For this purpose, 
first we synthesized RV gene 10 transcript using an in vitro tran-
scription kit (Ambion T7 MEGAscript). GTase reaction mixture 
(20 l) was prepared by adding 2 l of IVT (in vitro transcription) 
synthesized ssRNA (200 ng/l) with increasing concentrations of 
VP3 protein in GTase buffer [20 mM Hepes (pH 8.0), 150 mM NaCl, 
5 mM DTT, 5 mM MgCl2, and 5% glycerol], 2 l of [-32P] GTP, 
and 1 l of murine RNase inhibitor (New England Biolabs Inc.) 
with or without SAM (2 mM), followed by incubation at 30°C for 
3 hours. The reaction was stopped by incubating the reaction 
mixture at 70°C for 5 min and adding 2× RNA gel loading buffer II 
(Thermo Fisher Scientific). The reaction mixture was resolved on 
a 6% tris-borate-EDTA [Tris-borate-EDTA (TBE)]–urea gel (Thermo 
Fisher Scientific). After completely vacuum drying the gel, GTase 
activity was confirmed by autoradiography. The vaccinia capping 
system (New England Biolabs Inc.) was used as a positive control. 
We also used this reaction mixture to show transfer of a methyl 
group onto the RNA transcript. For that purpose, we purified the 
RNA from the above reaction mixture using the Zymo RNA clean and 
concentrator-5 kit (Zymo Research) and eluted the RNA in 7 l of 
RNase-free water. The eluted RNA was digested with P1 Nuclease in 
a 7-l reaction mixture: 5 l of purified RNA from the previous step, 
0.6 l of RNase-free water, 0.7 l of P1 Nuclease buffer [500 mM 
sodium acetate (pH 5.2)], and 0.7 l of P1 Nuclease (0.625 U/l). 
The reaction mixture was gently mixed and incubated at 37°C for 
30 min. Thin-layer chromatography (TLC) was run on a Macherey- 
Nagel Cellulose MN 300 PEI TLC plate (Fisher Scientific; prerun in 
RNase-free water and air-dried before loading the samples) in a 
0.4 M ammonium sulfate mobile phase. The TLC plate was com-
pletely air-dried, and the film was developed for autoradiography. 
Nonmethylated GpppG and methylated mGpppG (New England 
Biolabs Inc.) cap standards were used to mark the spots for the 
capped products. We also performed a colorimetric MTase assay 
with a commercially available MTase colorimetric assay kit (Cayman 
Chemical). The SAM-dependent MTase uses SAM as a methyl donor 
to transfer the methyl group on the substrate. The transfer of the 
methyl group from SAM (AdoMet) generates SAH (AdoHcy). The 
MTase assay kit detects the level of free SAH by a colorimetric reac-
tion. Briefly, a 20-l reaction mixture was prepared with increasing 
amounts of VP3, 2.5 mM nonmethylated cap analog (GpppG; New 
England Biolabs Inc.), and 1 mM SAM in MTase buffer [100 mM 
tris-HCl (pH 8.0), 150 mM NaCl, 2 mM MgCl2, and 5% glycerol]. 
The reaction mixture was incubated at 37°C for 1 hour. Further-
more, we added 100 l of the MTase colorimetric assay kit master 
mix with 15 l of the reaction mixture, followed by measuring the 
absorbance at 510 nm for 30 min on a FlexStation 3 (Molecular 
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Devices). RV VP8* was used as a negative control. For RTPase ac-
tivity, RV gene 10 transcript was synthesized using an in vitro tran-
scription kit (Ambion T7 MEGAshortscript T7 transcription kit) 
in the presence of 5 l of [-32P]-GTP, followed by 4 hours of in-
cubation at 37°C. RTPase reaction mixture (20 l) was prepared by 
adding 2 l of [-32P]-GTP 5′-end labeled gene 10 RNA with in-
creasing concentrations of VP3 and VP3-PDE domain proteins in 
RTPase buffer [20 mM Hepes (pH 8.0), 150 mM NaCl, 5 mM DTT, 
5 mM MgCl2, and 10% glycerol] and 1 l of murine RNase inhibitor 
(Invitrogen). The reaction mixture was incubated at room tem-
perature for 1 hour. The previously established RV NSP2 RTPase 
was used as a positive control (19). The reaction was stopped by 
adding 10 mM EDTA (pH 8) and 2× RNA gel loading buffer II 
(Thermo Fisher Scientific), followed by heating at 95°C for 5 min. 
The reaction mixture was resolved on a 6% TBE-urea gel (Ther-
mo Fisher Scientific). After completely vacuum drying the gel, 
RTPase activity was confirmed by autoradiography. For RNA helicase 
activity, a fluorescence resonance energy transfer–based assay was 
performed using a previously established protocol (53). Briefly, 
a dsRNA strand was prepared by mixing 6-fluorescin amidite (6-
FAM)–labeled RNA strand (6-FAM-5′-UAGUACCGCCACCCU-
CAGAACCUUUUUUUUUUUUUU-3′; Sigma-Aldrich) and a Black 
Hole Quencher (BHQ)–labeled quencher strand (5′-GGUUCU-
GAGGGUGGCCCUACUA-3′-BHQ; Sigma-Aldrich) at 2:1 molar 
ratio. RNA duplex formation reaction was set up in 25 mM Mops-
NaOH (pH 6.5) and RiboLock (Invitrogen; 10 U) buffer by heating 
at 99°C for 5 min, followed by incubation at 65°C for 30 min and 
then overnight incubation at 25°C. The RNA helicase assay was 
performed with increasing concentrations of VP3 in helicase buffer 
[25 mM Mops-NaOH (pH 6.5), 2.5 mM MgCl2, and 2 mM DTT], 4 U 
of RiboLock (Invitrogen), 50 nM dsRNA substrate, 5 mM ATP, 
and 100 nM DNA capture strand (5′-TAGTACCGCCACCCT-
CAGAACC-3′; IDT) in 50 l of reaction volume. Fluorescence 
intensity was measured on a FlexStation 3 (Molecular Devices; 
maximum excitation/emission, 494/516) at 37°C for 45 min at 20-s 
intervals. For ATP- and MgCl2- modulated helicase activity, the 
assay was performed with constant VP3 concentration (3 M) and 
varying concentrations of ATP or MgCl2 (1 to 5 mM).
Kinetics of RNA-VP3 and RNA-PDE binding using BLI
Octet RED96 instrument (ForteBio) was used to carry out BLI. 
Biotinylated 8-mer ssRNA (5′-rG.rG.rC.rU.rU.rU.rU.rA-3′; Dharmacon 
Inc.) was loaded onto streptavidin-coated biosensors (ForteBio) at a 
concentration of 0.02 M in BLI running buffer [50 mM Hepes (pH 8.0), 
200 mM NaCl, 2 mM DTT, and 2 mM MgCl2] for 600 s, resulting in 
capture levels of 0.4 to 0.6 nm within a row of eight tips. RNA-VP3 
or RNA-PDE association and dissociation curves were obtained 
through twofold serial dilutions of VP3 (250, 125, 62.5, 31.25, and 
15.625 nM) or PDE domain (125, 62.5, 31.25, and 15.625 nM), 
respectively, with buffer blanks by using the Octet acquisition soft-
ware. The binding data acquired were fitted to 2:1 binding model, 
respectively, using the Octet analysis software based on their R2 values 
(~0.99) and 2/degrees of freedom values (~0).
AUC of VP3
To determine the oligomeric state of VP3, AUC experiments were 
performed using a Beckman Coulter XL-A analytical ultracentrifuge 
equipped with a TiAn50 eight-hole rotor. Sedimentation velocity 
experiments were conducted using two-channel epon centerpiece 
(12 mm) and a quartz window at 3.5 M concentration. Sample 
(VP3; 420 l) and reference solution buffer [50 mM Hepes (pH 8.0), 
200 mM NaCl, 2 mM DTT, 2 mM MgCl2, and 5% glycerol; 440 l] 
were loaded into the cell. Before starting the experiment, the rotor 
was equilibrated at 25°C in the vacuum chamber for 1 to 2 hours. 
Absorbance (optical density at 280 nm) scans were collected at 1-min 
intervals during sedimentation at 40,000 rpm. The resulting scans 
were analyzed using the continuous distribution [c(s)] analysis 
module in the program SEDFIT (54). Partial specific volume of the 
proteins, solvent density (), and solvent viscosity () were calculated 
from standard tables using the program SEDNTERP (55).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/16/eaay6410/DC1
View/request a protocol for this paper from Bio-protocol.
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